News
The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.
Federal documents show he disagreed with conclusions the benefits outweighed the risk of side effects, which are rare.
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
Once again, a new strain of COVID has hit the country, and that includes Rhode Island. According to the Centers for Disease ...
5don MSN
Experts said that COVID-19 vaccines are expected to be effective against this variant known as "nimbus." Here's what to know ...
7don MSNOpinion
RFK Jr. turned the CDC's vaccine committee into an anti-vaccine panel, but it still heard evidence that his campaign against ...
NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent ...
The Occupational Safety and Health Administration (OSHA) this week proposed removing COVID-19 recordkeeping requirements for ...
2d
Smithsonian Magazine on MSNSix Questions About Covid-19 Vaccines, AnsweredRecent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...
The U.S. Food and Drug Administration is now requiring two common COVID-19 vaccines to update their warning labels to include ...
An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...
7d
News Medical on MSNUpdated COVID vaccine reduces risk of severe illness and death, especially for high-risk adultsA new multi-state study led by the Centers for Disease Control and Prevention's (CDC) VISION Network—including Regenstrief ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results